Abstract
One of the most exciting recent developments in cancer-related research has been the discovery and understanding of colony-stimulating factors. There is now a general optimism that these factors will be used in the treatment of a variety of solid tumors, lymphomas, and leukemias, as well as in the treatment of patients who are immunocompromised or undergoing bone marrow transplantation. We have gathered a distinguished panel of experts to discuss the current status of this rapidly moving field.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Additional information
A series of teleconferences has been organized under the auspices of Bristol-Myers to address several major current questions in oncology. A panel of recognized experts with a moderator has been assembled to discuss each question, and we are reporting a number of these discussions in Breast Cancer Research and Treatment. This is reprinted from ‘Oncology Viewpoints’, courtesy of Bristol-Myers Oncology Division, Evansville IN 47721, USA.
Rights and permissions
About this article
Cite this article
McGuire, W.L., Gabrilove, J., Moore, M.A.S. et al. Colony-stimulating factors. Breast Cancer Res Tr 14, 193–200 (1989). https://doi.org/10.1007/BF01810735
Issue Date:
DOI: https://doi.org/10.1007/BF01810735